Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Raphael Pharmaceutical Inc. (RAPH) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.23M |
|
-- |
|
-- |
|
$0.22M |
|
$-0.22M |
|
$0.01M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
$-0.22M |
|
20.18M |
|
20.18M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$1.67M |
|
-- |
|
-- |
|
$1.67M |
|
$-1.66M |
|
$-1.66M |
|
$-1.66M |
|
20.18M |
|
| Cash Flow Statement Financials | |
$-0.04M |
|
-- |
|
-- |
|
$0.04M |
|
$0.00M |
|
$-0.04M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
13.06% |
|
13.06% |
|
-7233.33% |
|
13.06% |
|
$-0.08 |
|
$-0.00 |
|
$-0.00 |
|